Literature DB >> 26548861

Human Peroxiredoxins 1 and 2 and Their Interacting Protein Partners; Through Structure Toward Functions of Biological Complexes.

Mariarita Bertoldi1.   

Abstract

Since their discovery in the mid-nineties, peroxiredoxins have drawn much attention and the number of papers publications on different Prxs has been multiplied. The rise in interest in this topic is probably due, at least in part, to the large and further increasing functions attributed to the members of this family of ubiquitous proteins, including many redox and non-redox physiological functions. This review presents a Since their discovery in the mid-nineties, peroxiredoxins have drawn much attention and the number of publications on different Prxs has been multiplied. The rise in interest in this topic is probably due, at least in part, to the large and further increasing functions attributed to the members of this family of ubiquitous proteins, including many redox and non-redox physiological functions. This review presents a literature survey of the protein partners of the human Peroxiredoxin-1 and Peroxiredoxin- 2 of the Peroxiredoxin 1 subfamily, the most abundant class. Three sequence motifs, or combinations thereof, were found in the protein partners, namely, CXXC, PXXP, and LXXLL. These findings are discussed in light of i) protein partner localization, function and biological pathways and ii) the peroxiredoxins regions important for partner interaction, as revealed by the Peroxiredoxin-1-Sulfiredoxin-1 complex structure. The outcome of these analyses is expected to unravel some common molecular bases underlying peroxiredoxins propensity to bind a partner, as well as to propose a functional role for this interaction that could help to widen the biological role of this important class of enzymes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26548861     DOI: 10.2174/0929866523666151106123720

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  7 in total

1.  Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA.

Authors:  Lin Deng; Xiang Gan; Masahiko Ito; Ming Chen; Hussein H Aly; Chieko Matsui; Takayuki Abe; Koichi Watashi; Takaji Wakita; Tetsuro Suzuki; Toru Okamoto; Yoshiharu Matsuura; Masashi Mizokami; Ikuo Shoji; Hak Hotta
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 2.  microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical In Vivo Models.

Authors:  Ulrich H Weidle; Ulrich Brinkmann; Simon Auslaender
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

Review 3.  Peroxiredoxins and Redox Signaling in Plants.

Authors:  Michael Liebthal; Daniel Maynard; Karl-Josef Dietz
Journal:  Antioxid Redox Signal       Date:  2017-07-13       Impact factor: 8.401

Review 4.  Role of Cytosolic 2-Cys Prx1 and Prx2 in Redox Signaling.

Authors:  Yosup Kim; Ho Hee Jang
Journal:  Antioxidants (Basel)       Date:  2019-06-10

5.  Tyrosine Phosphorylation Modulates Peroxiredoxin-2 Activity in Normal and Diseased Red Cells.

Authors:  Alessandro Mattè; Enrica Federti; Elena Tibaldi; Maria Luisa Di Paolo; Giovanni Bisello; Mariarita Bertoldi; Andrea Carpentieri; Pietro Pucci; Iana Iatchencko; Anand B Wilson; Veronica Riccardi; Angela Siciliano; Francesco Turrini; Dae Won Kim; Soo Young Choi; Anna Maria Brunati; Lucia De Franceschi
Journal:  Antioxidants (Basel)       Date:  2021-02-01

Review 6.  Thiol-Based Peroxidases and Ascorbate Peroxidases: Why Plants Rely on Multiple Peroxidase Systems in the Photosynthesizing Chloroplast?

Authors:  Karl-Josef Dietz
Journal:  Mol Cells       Date:  2016-01-25       Impact factor: 5.034

7.  Long Non-coding RNA CASC15 Promotes Intrahepatic Cholangiocarcinoma Possibly through Inducing PRDX2/PI3K/AKT Axis.

Authors:  Yuan Zhang; Lufei Zhang; Sinan Lu; Yucheng Xiang; Cheng Zeng; Tianyu He; Yuan Ding; Weilin Wang
Journal:  Cancer Res Treat       Date:  2020-10-05       Impact factor: 4.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.